AFLD proposes more testing for Armstrong samples

"For the sake of objectivity and justice, and to enable the cyclist Lance Armstrong dispel any unfounded rumors", the French Anti-Doping Agency (AFLD) proposed Wednesday to offer for analysis six of Armstrong's residual urine samples (B samples) taken during the 1999 Tour de France.

The Agency suggested testing the samples for recombinant EPO. Despite the elapsed nine years, at least five of the samples are considered by the AFLD to be in suitable condition and of sufficient volume to permit such testing. The samples were preserved at the French National Anti-Doping Lab (LNDD) following a January 4, 2006, court tribunal defamation decision involving Armstrong.

Thank you for reading 5 articles in the past 30 days*

Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read any 5 articles for free in each 30-day period, this automatically resets

After your trial you will be billed £4.99 $7.99 €5.99 per month, cancel anytime. Or sign up for one year for just £49 $79 €59

Join now for unlimited access

Try your first month for just £1 / $1 / €1

Laura Weislo
Managing Editor

Laura Weislo has been with Cyclingnews since 2006 after making a switch from a career in science. As Managing Editor, she coordinates coverage for North American events and global news. As former elite-level road racer who dabbled in cyclo-cross and track, Laura has a passion for all three disciplines. When not working she likes to go camping and explore lesser traveled roads, paths and gravel tracks. Laura specialises in covering doping, anti-doping, UCI governance and performing data analysis.